BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$774M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$304M |
| 3 |
Visa
V
|
+$297M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Broadcom
AVGO
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$531M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$335M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$232M |
| 4 |
DuPont de Nemours
DD
|
+$196M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.98% |
| 2 | Consumer Discretionary | 7.48% |
| 3 | Healthcare | 6.58% |
| 4 | Financials | 6.21% |
| 5 | Industrials | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Greif Class B
GEF.B
$4.28B
| $94.5K | ﹤0.01% |
1,432
-705
| -33% | -$46.6K |
|
3302
Citizens & Northern Corp
CZNC
$468M
| $93.4K | ﹤0.01% |
4,165
+1,642
| +65% | +$32.4K |
|
3303
West Bancorporation
WTBA
$510M
| $93.3K | ﹤0.01% |
4,401
+1,754
| +66% | +$31.3K |
|
3304
Gevo
GEVO
$396M
| $92.2K | ﹤0.01% |
79,500
-144,291
| -64% | -$165K |
|
3305
iShares US Healthcare ETF
IYH
$3.78B
| $91.6K | ﹤0.01% |
1,600
-25
| -2% | -$1.36K |
|
|
DRD
3306
DRDGold
DRD
$2.06B
| $91.3K | ﹤0.01% |
+11,488
| New | +$98.6K |
|
3307
Information Services Group
III
$242M
| $91.2K | ﹤0.01% |
19,365
-5,136
| -21% | -$22.5K |
|
3308
First Business Financial Services
FBIZ
$603M
| $91.1K | ﹤0.01% |
2,271
+886
| +64% | +$29.8K |
|
3309
Transcontinental Realty Investors
TCI
$327M
| $90.2K | ﹤0.01% |
2,610
-122
| -4% | -$3.77K |
|
3310
Farmers & Merchants Bancorp
FMAO
$487M
| $89.2K | ﹤0.01% |
3,595
-1,909
| -35% | -$37.8K |
|
|
SCPH
3311
DELISTED
scPharmaceuticals
SCPH
| $88.9K | ﹤0.01% |
14,182
-4,062
| -22% | -$23.3K |
|
3312
NewtekOne
NEWT
$378M
| $88.2K | ﹤0.01% |
6,393
-3,162
| -33% | -$44.2K |
|
3313
Peoples Financial Services
PFIS
$716M
| $88.2K | ﹤0.01% |
1,811
-1,042
| -37% | -$44.6K |
|
3314
Fate Therapeutics
FATE
$310M
| $87.4K | ﹤0.01% |
23,380
-217,195
| -90% | -$513K |
|
3315
KB Financial Group
KB
$41.7B
| $86.5K | ﹤0.01% |
2,092
-2,819
| -57% | -$114K |
|
|
AGEN
3316
Agenus
AGEN
$311M
| $86K | ﹤0.01% |
5,197
-9,707
| -65% | -$161K |
|
3317
Eldorado Gold
EGO
$10.1B
| $84.7K | ﹤0.01% |
6,528
-123
| -2% | -$1.38K |
|
3318
Warner Bros
WBD
$69.8B
| $84.1K | ﹤0.01% |
+7,389
| New | +$79.8K |
|
3319
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$797M
| $83.7K | ﹤0.01% |
2,811
-804
| -22% | -$22K |
|
3320
NWPX Infrastructure Inc
NWPX
$1.12B
| $83.2K | ﹤0.01% |
2,751
-1,265
| -31% | -$35.6K |
|
3321
SIGA Technologies
SIGA
$207M
| $83.1K | ﹤0.01% |
14,848
+1,979
| +15% | +$10.6K |
|
3322
RBB Bancorp
RBB
$464M
| $82.7K | ﹤0.01% |
4,344
-10,605
| -71% | -$158K |
|
3323
Coca-Cola Femsa
KOF
$23.1B
| $82.5K | ﹤0.01% |
872
-8,613
| -91% | -$718K |
|
3324
Home Bancorp
HBCP
$572M
| $81.7K | ﹤0.01% |
1,945
-4,204
| -68% | -$154K |
|
3325
Seres Therapeutics
MCRB
$45.1M
| $81.3K | ﹤0.01% |
2,902
-9,523
| -77% | -$250K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2023 Portfolio in Review
As of Q4 2023, BNP Paribas Financial Markets held 4,166 positions worth $88.1B, up 13% from $77.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets deployed $2.95B of net new capital in Q4 2023, opening 246 new positions and adding to 1,677 existing holdings. Its largest new stake was State Street Blackstone Senior Loan ETF: 590,458 shares worth $24.8M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $531M trimmed.
- BNP Paribas Financial Markets's largest Q4 2023 buy was State Street Blackstone Senior Loan ETF: 590,458 shares worth $24.8M.
- BNP Paribas Financial Markets added most to Amazon in Q4 2023, an estimated $774M increase.
- BNP Paribas Financial Markets's biggest Q4 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $531M.
- BNP Paribas Financial Markets fully exited VMware, Inc in Q4 2023, selling an estimated $66.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $88.1B portfolio in Q4 2023.
- BNP Paribas Financial Markets opened 246 new positions and closed 164 in Q4 2023.
- BNP Paribas Financial Markets's portfolio value rose 13% quarter-over-quarter to $88.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2023, filed 7 Feb 2024.